Goodwin Procter LLP advised Quanta Dialysis Technologies on the deal, while Latham & Watkins advised Novo Holdings. Quanta Dialysis Technologies announced its completion of a $245 million…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
